Yes — results are overdue. Primary completion was 2017-05-12; the FDAAA-801 reporting deadline (2018-05-12) passed 2962 days ago and no results are posted on ClinicalTrials.gov.
| NCT ID | NCT03082300 ↗ |
|---|---|
| Sponsor | Astellas Pharma Global Development, Inc. (INDUSTRY) |
| Phase | PHASE1 |
| Status | TERMINATED |
| Primary completion | 2017-05-12 (ACTUAL) |
| Reporting deadline | 2018-05-12 (completion + 365d) |
| Days overdue | 2962 |
| Results posted | No — check results tab ↗ |
| FDA-regulated | drug: yes, device: no |
| Provenance | Flagged overdue on 2026-06-21 · SHA-256 6dc893c028b9bdd2… (hash-chained, tamper-evident) |
Source of record: ClinicalTrials.gov NCT03082300. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.